# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Xylem reported strong Q2 results, with revenue growth of 26%, adjusted EPS of $1.09, and raised its full-year guidance.